0001179110-13-000738.txt : 20130109 0001179110-13-000738.hdr.sgml : 20130109 20130109173046 ACCESSION NUMBER: 0001179110-13-000738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130107 FILED AS OF DATE: 20130109 DATE AS OF CHANGE: 20130109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Christopher G CENTRAL INDEX KEY: 0001537668 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 13521190 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2013-01-07 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001537668 White Christopher G 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Business Officer Common Stock 2013-01-07 4 S 0 4000 16.0712 D 2000 D Common Stock 2013-01-07 4 M 0 4000 A 6000 D Common Stock 2013-01-08 4 S 0 3000 15.8665 D 3000 D Common Stock 2013-01-09 4 S 0 3000 15.8022 D 0 D Restricted Stock Units 2013-01-07 4 M 0 4000 A Common Stock 4000 4000 D The sale reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.79-$16.24. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc. (the "Issuer"), or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares were acquired by the reporting person as a result of the partial vesting of the restricted stock unit grant described below. Not applicable. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.69-$16.08. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.52-$16.04. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Grant of restricted stock unit pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in three installments as follows: 50% on January 7, 2012, 25% on January 7, 2013 and the remaining 25% on January 7, 2014. Nancy R. Smith, attorney-in-fact 2013-01-09